EP3986890
Bensísoxasól-súlfónamíð-afleiður
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.6.2020EP published:
15.11.2023EP application number:
20743773.2
EP translation filed:
11.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
15.6.2040Expiry date:
15.6.2026Next due date:
30.6.2026
Title in English:
BENZISOXAZOLE SULFONAMIDE DERIVATIVESLanguage of the patent:
English
Timeline
Today
16.6.2020EP application
15.11.2023EP Publication
11.12.2023Translation submitted
15.1.2024Registration published
15.6.2026Expires
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Name:
CTXT PTY LTDAddress:
305 Grattan Street Parkville, Melbourne, VIC 3000, AU
Inventor
Name:
BOZIKIS, Ylva Elisabet BergmanAddress:
Parkville, Victoria 3052, AU
Name:
BRODSKY, OlegAddress:
San Diego, California 92121, US
Name:
CAMERINO, Michelle AngAddress:
Parkville, Victoria 3052, AU
Name:
GREASLEY, Samantha ElizabethAddress:
San Diego, California 92121, US
Name:
HOFFMAN, Robert LouisAddress:
San Diego, California 92121, US
Name:
KUMPF, Robert ArnoldAddress:
San Diego, California 92121, US
Name:
KUNG, Pei-PeiAddress:
San Diego, California 92121, US
Name:
RICHARDSON, Paul FrancisAddress:
San Diego, California 92121, US
Name:
STUPPLE, Paul AnthonyAddress:
Parkville, Victoria 3052, AU
Name:
SUTTON, Scott ChanningAddress:
San Diego, California 92121, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962863199 PDate:
18.6.2019Country:
US
Number:
201962953223 PDate:
24.12.2019Country:
US
Number:
202063025278 PDate:
15.5.2020Country:
US
Classification
Categories:
C07D 413/06, A61K 31/41, A61K 31/4192, A61K 31/4402, A61K 31/497, A61K 31/506, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 29.4.2024
Expires: 15.6.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 30.5.2025
Expires: 15.6.2026
Payer: Árnason Faktor ehf.